Calamos Advisors »

Ascendis Pharma A S shares owned by Calamos Advisors

Quarter-by-quarter ownership of Ascendis Pharma A S (ASND) shares owned by Calamos Advisors from 13F filings

Historical chart of Calamos Advisors investment in Ascendis Pharma A S

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma A S held by Calamos Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma A S by Calamos Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.5M 16k 213.24
2025-09-30 $1.3M 6.5k 198.81

More positions owned by Calamos Advisors

NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Western Digital Corp Note 3.000%11/1 (Principal)
Alibaba Group Hldg Note 0.500% 6/0 (Principal)
Eli Lilly & Co. (LLY)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr Russell 2000 Etf (IWM)

View all positions for Calamos Advisors

Top funds holding Ascendis Pharma A S

RA Capital Management
Westfield Capital Management Company
venBio Select Advisor
FMR
Henderson Group
Artisan Partners Limited Partnership
Capital Research and Management Company - Division 3
Franklin Resources
Massachusetts Financial Services
Wellington Management Company
T. Rowe Price Investment Management
American Century Companies
Perceptive Advisors
Principal Financial Group
Susquehanna International

View all funds holding Ascendis Pharma A S